{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,27]],"date-time":"2024-06-27T00:28:01Z","timestamp":1719448081834},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,6,26]]},"DOI":"10.7759\/cureus.63217","type":"journal-article","created":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T16:53:38Z","timestamp":1719420818000},"source":"Crossref","is-referenced-by-count":0,"title":["Subacute Cutaneous Lupus Erythematosus Secondary to Intravenous Immunoglobulin Infusions"],"prefix":"10.7759","author":[{"given":"Taylor","family":"Fleshman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Depew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Snider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.984229","article-title":"Clinical aspects of cutaneous lupus erythematosus","volume":"9","author":"Elmgren J","year":"2022","unstructured":"Elmgren J, Nyberg F. Clinical aspects of cutaneous lupus erythematosus. Front Med (Lausanne). 2022, 9:984229. 10.3389\/fmed.2022.984229","journal-title":"Front Med (Lausanne)"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2007.06554.x","article-title":"Clinical manifestations of cutaneous lupus erythematosus","volume":"5","author":"Kuhn A","year":"2007","unstructured":"Kuhn A, Sticherling M, Bonsmann G. Clinical manifestations of cutaneous lupus erythematosus. J Dtsch Dermatol Ges. 2007, 5:1124-37. 10.1111\/j.1610-0387.2007.06554.x","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(98)70497-9","article-title":"Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: Diagnostic criteria and therapeutic implications","volume":"3","author":"Chlebus E","year":"1998","unstructured":"Chlebus E, Wolska H, Blaszczyk M, Jablonska S. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: Diagnostic criteria and therapeutic implications. J Am Acad Dermatol. 1998, 3:405-12. 10.1016\/s0190-9622(98)70497-9","journal-title":"J Am Acad Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10272.x","article-title":"Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden","volume":"164","author":"Gr\u00f6nhagen CM","year":"2011","unstructured":"Gr\u00f6nhagen CM, Fored CM, Granath F, Nyberg F. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol. 2011, 164:1335-41. 10.1111\/j.1365-2133.2011.10272.x","journal-title":"Br J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.316","article-title":"From pathogenesis, epidemiology, and genetics to definitions, diagnosis, and treatments of cutaneous lupus erythematosus and dermatomyositis: a report from the 3rd International Conference on Cutaneous Lupus Erythematosus (ICCLE) 2013","volume":"135","author":"Schultz HY","year":"2015","unstructured":"Schultz HY, Dutz JP, Furukawa F, et al.. From pathogenesis, epidemiology, and genetics to definitions, diagnosis, and treatments of cutaneous lupus erythematosus and dermatomyositis: a report from the 3rd International Conference on Cutaneous Lupus Erythematosus (ICCLE) 2013. J Invest Dermatol. 2015, 135:7-12. 10.1038\/jid.2014.316","journal-title":"J Invest Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2008.02806.x","article-title":"Pathogenesis of subacute cutaneous lupus erythematosus","volume":"22","author":"Stavropoulos PG","year":"2008","unstructured":"Stavropoulos PG, Goules AV, Avgerinou G, Katsambas AD. Pathogenesis of subacute cutaneous lupus erythematosus. J Eur Acad Dermatol Venereol. 2008, 22:1281-9. 10.1111\/j.1468-3083.2008.02806.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.23736\/S0392-0488.18.05929-1","article-title":"Cutaneous lupus erythematosus: clinico-pathologic correlation","volume":"153","author":"Filotico R","year":"2018","unstructured":"Filotico R, Mastrandrea V. Cutaneous lupus erythematosus: clinico-pathologic correlation. G Ital Dermatol Venereol. 2018, 153:216-29. 10.23736\/S0392-0488.18.05929-1","journal-title":"G Ital Dermatol Venereol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.10110.x","article-title":"A systematic review of drug-induced subacute cutaneous lupus erythematosus","volume":"164","author":"Lowe GC","year":"2011","unstructured":"Lowe GC, Henderson CL, Grau RH, Hansen CB, Sontheimer RD. A systematic review of drug-induced subacute cutaneous lupus erythematosus. Br J Dermatol. 2011, 164:465-72. 10.1111\/j.1365-2133.2010.10110.x","journal-title":"Br J Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-008-0895-5","article-title":"Drug-induced lupus erythematosus","volume":"301","author":"Vedove CD","year":"2009","unstructured":"Vedove CD, Del Giglio M, Schena D, Girolomoni G. Drug-induced lupus erythematosus. Arch Dermatol Res. 2009, 301:99-105. 10.1007\/s00403-008-0895-5","journal-title":"Arch Dermatol Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/jns.12218","article-title":"Drug-induced cutaneous lupus erythematosus after immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a case series","volume":"22","author":"Adrichem ME","year":"2017","unstructured":"Adrichem ME, Starink MV, van Leeuwen EM, Kramer C, van Schaik IN, Eftimov F. Drug-induced cutaneous lupus erythematosus after immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a case series. J Peripher Nerv Syst. 2017, 22:213-18. 10.1111\/jns.12218","journal-title":"J Peripher Nerv Syst"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.12998","article-title":"Intravenous immunoglobulin G use in patients with chronic inflammatory demyelinating polyneuropathy: an uncommon cause of drug-induced discoid lupus erythematosus","volume":"60","author":"Jennings T","year":"2019","unstructured":"Jennings T, Ahmed S, Aphale A, Lee J, Valdes-Rodriguez R. Intravenous immunoglobulin G use in patients with chronic inflammatory demyelinating polyneuropathy: an uncommon cause of drug-induced discoid lupus erythematosus. Australas J Dermatol. 2019, 60:e208-10. 10.1111\/ajd.12998","journal-title":"Australas J Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.02.009","article-title":"Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study","volume":"81","author":"Guicciardi F","year":"2019","unstructured":"Guicciardi F, Atzori L, Marzano AV, et al.. Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study. J Am Acad Dermatol. 2019, 81:403-11. 10.1016\/j.jaad.2019.02.009","journal-title":"J Am Acad Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.10969.x","article-title":"Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden","volume":"167","author":"Gr\u00f6nhagen CM","year":"2012","unstructured":"Gr\u00f6nhagen CM, Fored CM, Linder M, Granath F, Nyberg F. Subacute cutaneous lupus erythematosus and its association with drugs: a population-based matched case-control study of 234 patients in Sweden. Br J Dermatol. 2012, 167:296-305. 10.1111\/j.1365-2133.2012.10969.x","journal-title":"Br J Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10397.x","article-title":"Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart","volume":"165","author":"Marzano AV","year":"2011","unstructured":"Marzano AV, Lazzari R, Polloni I, Crosti C, Fabbri P, Cugno M. Drug-induced subacute cutaneous lupus erythematosus: evidence for differences from its idiopathic counterpart. Br J Dermatol. 2011, 165:335-41. 10.1111\/j.1365-2133.2011.10397.x","journal-title":"Br J Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2013.07.008","article-title":"Cutaneous lupus erythematosus: diagnosis and treatment","volume":"27","author":"Okon LG","year":"2013","unstructured":"Okon LG, Werth VP. Cutaneous lupus erythematosus: diagnosis and treatment. Best Pract Res Clin Rheumatol. 2013, 27:391-404. 10.1016\/j.berh.2013.07.008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-7125(16)30620-4","article-title":"Subacute cutaneous lupus erythematosus: a decade's perspective","volume":"73","author":"Sontheimer RD","year":"1989","unstructured":"Sontheimer RD. Subacute cutaneous lupus erythematosus: a decade's perspective. Med Clin North Am. 1989, 73:1073-90. 10.1016\/s0025-7125(16)30620-4","journal-title":"Med Clin North Am"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000704","article-title":"Treatment of cutaneous lupus erythematosus: current approaches and future strategies","volume":"32","author":"Shi H","year":"2020","unstructured":"Shi H, Gudjonsson JE, Kahlenberg JM. Treatment of cutaneous lupus erythematosus: current approaches and future strategies. Curr Opin Rheumatol. 2020, 32:208-14. 10.1097\/BOR.0000000000000704","journal-title":"Curr Opin Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2010.03844.x","article-title":"Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI","volume":"25","author":"Bein D","year":"2011","unstructured":"Bein D, Kuehn E, Meuth AM, et al.. Evaluation of disease activity and damage in different subtypes of cutaneous lupus erythematosus using the CLASI. J Eur Acad Dermatol Venereol. 2011, 25:652-9. 10.1111\/j.1468-3083.2010.03844.x","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12922","article-title":"Anti-SSA antibodies are present in immunoglobulin preparations","volume":"55","author":"van der Molen RG","year":"2015","unstructured":"van der Molen RG, Hamann D, Jacobs JF, et al.. Anti-SSA antibodies are present in immunoglobulin preparations. Transfusion. 2015, 55:832-7. 10.1111\/trf.12922","journal-title":"Transfusion"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/251585-subacute-cutaneous-lupus-erythematosus-secondary-to-intravenous-immunoglobulin-infusions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,26]],"date-time":"2024-06-26T16:53:44Z","timestamp":1719420824000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/251585-subacute-cutaneous-lupus-erythematosus-secondary-to-intravenous-immunoglobulin-infusions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,26]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.63217","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,26]]}}}